Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Air space consolidation results when alveoli are filled with material that attenuates the x-ray beam more than the surrounding lung parenchyma. When encountered in the acute setting, air space consolidation on imaging has a differential diagnosis ( Table 14.1 ).
DIAGNOSIS | COMMENTS |
---|---|
Infectious pneumonia | Alveoli are filled with pus or inflammatory fluid; fever and leukocytosis are often present |
Aspiration of gastric contents | There is a predilection for gravity-dependent lung segments; Mendelson syndrome refers to chemical pneumonitis from aspiration during obstetric anesthesia |
Alveolar pulmonary edema | Cardiomegaly and pleural effusions may be present; acute respiratory distress syndrome may be considered in severe cases |
Pulmonary hemorrhage | Consider pulmonary contusion in the setting of trauma; there may be a history of anticoagulation or bleeding diathesis |
Pulmonary infarction | Risk factors for pulmonary embolism are present; consolidation is peripheral and is more likely in the lower lobes |
When air space consolidation persists on imaging studies over several weeks to months, the differential diagnosis shifts away from pneumonia, which typically has a more acute presentation, with subsequent resolution. Infectious, inflammatory, and neoplastic causes should be considered when chronic air space consolidation is encountered ( Fig. 14.1 ), and the most common entities are outlined in Table 14.2 .
DIAGNOSIS | COMMENTS |
---|---|
Organizing pneumonia | Reverse halo sign seen in up to 20%; consolidation typically responds to steroid therapy |
Chronic eosinophilic pneumonia | Often elevated eosinophils in bronchoalveolar lavage fluid and peripheral blood; upper lobe predominant consolidation; typically responds to steroid therapy |
Poorly treated infection | May be due to suboptimal antibiotic choice or resistance; also consider fungal and mycobacterial infection |
Adenocarcinoma | Air bronchograms may be seen |
Sarcoidosis | Confluent granulomatous nodules may mimic consolidation |
Lymphoma | Usually derived from bronchus-associated lymphoid tissue; air bronchograms may be seen |
Lipoid pneumonia | Demonstrates areas of fat attenuation; generally indolent course |
Churg-Strauss syndrome | Nearly all patients have asthma and eosinophilia |
The differential diagnosis of a solitary pulmonary nodule on chest radiography or CT is broad, but more than 95% of the time the nodule is an infectious granuloma ( Fig. 14.2 ), malignant neoplasm (primary or metastatic), or benign tumor (e.g., a hamartoma). Nodule size, shape, density, calcification pattern, degree of contrast enhancement, fluorodeoxyglucose (FDG) avidity, and rate of growth are key imaging characteristics that when combined with clinical factors (e.g., patient age, immune status, clinical history) help narrow the differential diagnosis. Ultimately, this combination of factors may indicate a nodule's likelihood of benignity versus malignancy or even provide a specific diagnosis. There are many possible causes of a solitary pulmonary nodule ( Table 14.3 ).
DIAGNOSIS | COMMENTS |
---|---|
Granuloma | May be other calcified granulomas or calcified lymph nodes; likelihood dependent on where patient has lived (far more common in Midwestern United States) |
Lung cancer | Calcification seen in 6%–7%; most lung cancers double in volume every 1–18 months |
Metastasis | Patients with melanoma, testicular cancer, or sarcoma more likely to have a solitary metastasis than primary lung cancer |
Intrapulmonary lymph node | Often found along fissures or in a subpleural location; morphology may be triangular, oval, round, or trapezoidal |
Pulmonary nodule mimic | Consider clothing artifact (button), nipple shadow, skin or chest wall lesion, healing rib fracture, and enostosis in a rib |
Hamartoma | Fat within a nodule nearly pathognomonic; popcorn calcification sometimes present |
Pulmonary carcinoid | Location generally more central; can enhance avidly; high false-negative rate on FDG PET imaging |
Infection (nongranulomatous) | Round pneumonia, septic embolus, or abscess |
Mesenchymal or neural tumor | Consider fibroma, chondroma, lipoma, or neurofibroma |
Arteriovenous malformation | Feeding artery and draining vein; multiple in hereditary hemorrhagic telangiectasia |
Inflammatory nodule | Rheumatoid nodule or granulomatosis with polyangiitis |
Diseases that involve the centrilobular bronchioles, pulmonary arterioles, or lymphatics may produce multiple centrilobular nodules. These nodules characteristically are evenly spaced from one another and spare the interlobular septa and pleural surfaces ( Fig. 14.3 ). Nodules in this distribution may be solid or of ground-glass attenuation, and the most common entities producing this pattern are outlined in Table 14.4 . If the nodules are branching, with a V or Y shape, it is termed a tree-in-bud pattern .
DIAGNOSIS | COMMENTS |
---|---|
Hypersensitivity pneumonitis | Ground-glass nodules; exposure to organic antigen identified in 50%; air trapping usually present |
Respiratory bronchiolitis | Upper lobe predominant ground-glass nodules; history of cigarette smoking |
Pulmonary arterial hypertension; pulmonary capillary hemangiomatosis; pulmonary veno-occlusive disease | Ground-glass nodules; due to pulmonary edema and/or hemorrhage; dilated main pulmonary trunk |
Metastatic calcification | Upper lobe ground-glass nodules ± calcification; hypercalcemia |
Endobronchial infection, bronchopneumonia | Solid or ground-glass ± tree-in-bud opacities; bacterial, viral, or fungal causes |
Follicular bronchiolitis | Solid or ground-glass nodules ± tree-in-bud opacities; immunosuppression or connective tissue disease |
Pneumoconioses | Solid centrilobular nodules; especially siderosis and coal workers' pneumoconiosis |
Langerhans cell histiocytosis | Upper lobe predominant solid or ground-glass nodules; early in disease course; history of cigarette smoking |
On CT imaging, diseases that involve the perilymphatic channels are typically subpleural and are along bronchovascular bundles, interlobular septae, and fissures. Unlike centrilobular nodules, nodules with a perilymphatic distribution are generally unevenly spaced from one another. There are several diagnostic considerations for nodules with a perilymphatic distribution ( Table 14.5 ).
DIAGNOSIS | COMMENTS |
---|---|
Pulmonary sarcoidosis | Concomitant symmetric hilar and mediastinal lymph nodes; patients commonly between 20 and 40 years of age |
Silicosis and coal workers' pneumoconiosis | Nodules range from 1–10 mm in diameter; nodules have an upper lobe and posterior distribution |
Lymphangitic carcinomatosis | Adenocarcinoma (lung and breast) most common cause; associated pleural effusions are common |
Nodular pulmonary amyloidosis | Patients usually in sixth decade of life and often asymptomatic; lower lobe and peripheral distribution often appreciated |
Lymphocytic interstitial pneumonia | Associated with HIV (in children) and Sjögren syndrome; scattered thin-walled perivascular cysts often present |
Multiple pulmonary nodules that are diffusely distributed and without architectural predominance—that is, lack a centrilobular or peribronchovascular distribution—are likely random. These nodules may be variable in number and density, and often the underlying pathophysiologic mechanism is hematogenous dissemination. There are several diagnoses to consider when pulmonary nodules are found to have a random distribution ( Table 14.6 ).
DIAGNOSIS | COMMENTS |
---|---|
Hematogenous metastases | Lower lobe predominance; metastases may be small in size, as from thyroid cancer, or may be large (cannonball), as from seminoma |
Fungal infection | Can be miliary or larger; histoplasmosis, blastomycosis, and coccidioidomycosis; aspergillosis or zygomycosis in the immunocompromised |
Miliary tuberculosis | May be seen in primary or postprimary infection; miliary nodules imply active infection and poor prognosis |
Septic emboli | Peripheral and lower lobe predominance ± cavitation |
Adenocarcinoma of lung | Rarely presents as multiple nodules in a random distribution |
Rheumatoid necrobiotic nodules | Nodules wax and wane with rheumatoid arthritis activity; miliary nodularity occurs early, prior to pulmonary fibrosis |
Amyloidosis | Nodules may cavitate and/or show calcification |
Granulomatosis with polyangiitis | Nodules ± cavitation |
Benign metastasizing leiomyoma | Often a history of hysterectomy for uterine leiomyomas; nodules enhance with contrast and may cavitate |
A variety of disease entities can present with multiple calcified pulmonary nodules, with causes that include neoplastic, infectious, metabolic, and inhalational factors ( Fig. 14.4 ). Clinical history and the size, appearance, and distribution of the nodules can add specificity. The most common entities producing multiple calcified pulmonary nodules are outlined in Table 14.7 .
DIAGNOSIS | COMMENTS |
---|---|
Chronic granulomatous disease | Tuberculosis and histoplasmosis most common; may be associated findings such as calcified lymph nodes |
Metastatic disease | History of sarcoma or medullary thyroid cancer; mucinous adenocarcinoma metastases may calcify; treated choriocarcinoma metastases may calcify |
Pneumoconioses | Particularly silicosis and coal workers' pneumoconiosis |
Healed varicella pneumonia | Generally 2–3 mm in size; diffuse distribution |
Pulmonary alveolar microlithiasis | Sandlike calcifications, often ≈1 mm in size; lower lobe predominant |
Metastatic calcification | Upper lobe predominant; centrilobular ground-glass nodules; hypercalcemia |
Pulmonary amyloidosis | May be associated with tracheobronchial amyloidosis |
Multiple chondromas | One component of the Carney triad—paragangliomas, gastrointestinal stromal tumors, pulmonary chondromas |
A cavitary lung nodule usually contains air, but may also contain blood, pus, or debris. A cavitary nodule has a definite wall with thickness of at least 4 mm and should not be confused with a cyst, which is a thin-walled, air-containing lesion. Chest radiography may identify cavitary nodules, although CT offers increased sensitivity and provides improved lesion localization and characterization. There are several entities to consider when cavity pulmonary nodules are encountered ( Table 14.8 ).
DIAGNOSIS | COMMENTS |
---|---|
Pneumonia and lung abscess | Typically from Staphylococcus aureus, Pseudomonas aeruginosa , or Klebsiella pneumoniae; tuberculosis and fungal pneumonia also cavitate |
Metastases | Usually a primary squamous or transitional cell carcinoma; nodules often have round, well-demarcated borders |
Primary lung cancer | Squamous cell carcinoma most likely to cavitate; cavitation most likely when mass is >3 cm |
Pulmonary emboli | Lower lobe and peripheral distribution; septic emboli cavitate more commonly than bland emboli |
Granulomatosis with polyangiitis | Cavitation occurs in nearly 50% of patients with nodules; nodule size variable; may be associated with consolidation |
Rheumatoid lung nodules | Occur in <1% of rheumatoid arthritis patients; more common in men and in upper and middle lung zones |
Congenital lesions | Congenital pulmonary airway malformation; pulmonary sequestration |
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here